Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer

Overview of attention for article published in Frontiers in oncology, September 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,656 followers.

RT @FrontOncology: New research: Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer: Immuno…

12 Sep 2023

Reply Repost Favourite

New research: Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer: Immunotherapy has revolutionized the treatment of metastatic non-small cell lung cancer (NSCLC). Oligometastasis has been… #oncology https://t

12 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.